Category: Technology | Published: 2026-06-09
In 1957, the Soviet Union launched Sputnik and changed everything about how humanity thought about what was possible. The name SpudCell is partly a nod to that moment. Its creators at the University of Minnesota believe they may have done something comparable, not for space, but for biology.
Professor Kate Adamala, who led the research alongside Professor Aaron Engelhart, put it directly: they are hoping to start the true age of the bioeconomy, building enabling technology that will let people engineer biology in ways that were previously impossible.
What SpudCell actually is, what it can and cannot do, and why it matters well beyond the laboratory is worth understanding carefully, because the claims are significant and the caveats are equally important.
What Makes This Different From Previous Attempts
Before SpudCell, researchers working on artificial cells generally took one of two approaches. One was to start with a natural cell and remove genes until reaching the smallest viable genome, essentially stripping a living thing down to its minimum rather than building something new. The other was to demonstrate individual behaviours in isolation: copying DNA inside a membrane here, triggering growth there, but never combining the full set of things a cell needs to do into one coherent system.
SpudCell takes a third path. It was built from scratch using nonliving chemical components, each one specified and placed deliberately by the researchers. There is no natural organism at the origin of it. Everything inside it was chosen, which means everything inside it is known.
Biotic, the public-benefit organisation launched alongside the research, describes this as the key to the scientific value: a system we can fully specify is a system we can understand and change.
The Architecture: Small Genome, Modular Design
SpudCell's genome spans roughly 90,000 base pairs, distributed across seven separate DNA molecules known as plasmids. That figure matters for a specific reason: previous estimates suggested that the minimum genome needed to support a complete synthetic cell cycle might be around 113,000 base pairs. SpudCell does it with considerably less, demonstrating that artificial cell research may not require the genetic complexity that scientists once assumed.
The protein-making system uses 36 purified enzymes together with ribosomes, the molecular machines that translate genetic instructions into proteins. The fatty outer membrane encloses all of this, acting as both the boundary and the interface through which the cell interacts with its environment.
The modular architecture across seven plasmids is not merely a technical convenience. Each module handles a distinct function, which means researchers can swap out individual components, alter specific genes, and observe what changes without disrupting the rest of the system. That kind of experimental control is essentially impossible with natural cells, where everything is entangled with everything else in ways that are still only partially understood.
How SpudCell Feeds
One of the fundamental challenges in building an artificial cell is nutrition. Natural cells run on extraordinarily complex metabolic processes developed over billions of years of evolution. Recreating all of that from scratch would require a genome orders of magnitude larger than SpudCell's.
The researchers solved this pragmatically. Rather than building an internal metabolism, they supply SpudCell with feeder packages: small liposomes carrying lipids for membrane growth, ribosomes, enzymes, and other necessary molecules. A protein whose instructions are encoded in SpudCell's own DNA allows the cell to recognise, connect with, and fuse with these feeders, incorporating their contents.
This means the genome directly influences feeding success. Cells whose DNA produces more of the relevant fusion protein can access nutrition more efficiently, grow faster, and reach a larger size before dividing. The connection between genetic instruction and physical outcome is direct and observable.
How It Divides Without an Internal Skeleton
The division problem was another significant engineering challenge. Many natural cells rely on an internal cytoskeleton, a complex scaffolding of proteins that coordinates cell division, pulls genetic material apart, and organises the physical process of splitting into two daughter cells. Rebuilding a cytoskeleton from scratch would be enormously complicated and would require many proteins to work together correctly.
SpudCell takes a different route. It produces proteins that accumulate on the inside surface of the membrane. As these proteins crowd together, they create mechanical stress on the membrane until it eventually deforms and splits, producing two daughter cells. No cytoskeleton required.
This is not just an engineering workaround. It creates a direct genetic link to reproductive success: cells that produce more of the relevant protein divide more effectively. Which leads to the most striking finding of all.
Evolution in an Artificial Chemical System
The research team introduced a genetic change that increased production of the fusion protein responsible for feeding. The altered cells grew approximately 50 per cent faster than the originals. After five generations, the modified version was outcompeting its predecessor. When nutrients were made scarce, the advantage grew larger still.
This is Darwinian selection, the same process that drives evolution in natural life, running in a system that was assembled from defined chemical components in a laboratory. Not adapted from something that was already alive. Not modified from a natural organism. Built, and then observed to evolve.
Biotic describes this as selection running in a system that was built, not born, assembled from defined parts rather than carved down from something already alive.
What SpudCell Cannot Do
The researchers are careful and specific about the limitations, and those limitations are substantial.
SpudCell cannot make its own ribosomes. It depends on the ribosomes supplied in the feeder packages to produce proteins, which means it is not self-sustaining in the way a bacterium is. It requires carefully controlled laboratory conditions and regular resupply of feeder material to continue functioning. Its genome is not reliably passed on in full to every daughter cell, meaning the inheritance process still has significant engineering problems to solve before artificial cells of this type could operate independently across many generations.
The research is currently available as a preprint, meaning peer review is ongoing and the scientific community has not yet formally validated the findings.
Is SpudCell Alive?
The researchers say no, or at least not yet, and they are clear about this. SpudCell performs several things that living organisms do: it feeds, grows, copies its genome, divides, and shows selection pressure across generations. But it cannot sustain itself without external support, and it was constructed from components rather than derived from life.
Biotic's own framing is precise: SpudCell was constructed, not created, and its makers do not claim to have built life.
The scientific importance does not depend on resolving that definitional question. What matters is that researchers now have an artificial cell system whose components are fully known and can be deliberately changed, one at a time, to study what each element contributes to the behaviour of the whole. That is a research tool of remarkable potential regardless of whether SpudCell meets any given definition of life.
What This Research Could Eventually Enable
Artificial cell research at this level of sophistication points toward several practical applications, though most remain well in the future.
Programmable artificial cells that respond to specific biological signals could eventually be used in targeted drug delivery, releasing a therapeutic agent only in the presence of particular conditions within the body. Engineered artificial cells could act as biological manufacturing units, producing specific proteins, enzymes, or chemical compounds. Synthetic cell systems that model particular disease processes could give researchers better tools for understanding what goes wrong at a cellular level and testing interventions before any clinical application.
Perhaps most intriguingly, the convergence of artificial cell research with AI is beginning to attract serious attention. AI tools are already being used to design novel proteins and predict how biological molecules will behave. As artificial cell systems become more sophisticated, the ability to computationally design and test components before physically building them could accelerate the field considerably.
Why Businesses Should Be Paying Attention
Breakthroughs in synthetic biology rarely feel immediately relevant to the day-to-day concerns of running a business. But the pattern of transformative technology tends to follow a similar shape: a scientific milestone that seems distant from commercial application, followed by a period of rapid development, followed by applications that arrive faster than most organisations anticipated.
Understanding how emerging technologies are developing, and what they are likely to mean for industries from pharmaceuticals to manufacturing to materials science, is increasingly part of strategic awareness for businesses that want to stay ahead rather than react.
If you want to understand how AI and emerging technology are reshaping the business landscape, our AI Consultancy page is a practical starting point for conversations about what that means for your organisation specifically.